Endoscopic ulcers are neither meaningful nor validated as a surrogate for clinically significant upper gastrointestinal harm.
作者信息
Graham David Y
出版信息
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1147-50. doi: 10.1016/j.cgh.2009.06.006. Epub 2009 Jun 25.
Abstract
摘要
相似文献
1
Endoscopic ulcers are neither meaningful nor validated as a surrogate for clinically significant upper gastrointestinal harm.
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1147-50. doi: 10.1016/j.cgh.2009.06.006. Epub 2009 Jun 25.
2
Evidence for endoscopic ulcers as meaningful surrogate endpoint for clinically significant upper gastrointestinal harm.
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1156-63. doi: 10.1016/j.cgh.2009.03.032. Epub 2009 Apr 9.
3
Endoscopic ulcers as a surrogate marker of NSAID-induced mucosal damage.
Arthritis Res Ther. 2013;15 Suppl 3(Suppl 3):S4. doi: 10.1186/ar4176. Epub 2013 Jul 24.
4
Upper gastrointestinal bleeding: a complication of "inlet patch mucosa" in the upper esophagus.
Endoscopy. 1995 Mar;27(3):282. doi: 10.1055/s-2007-1005690.
5
Hiatal hernia with cameron ulcers and erosions.
Gastrointest Endosc Clin N Am. 1996 Oct;6(4):671-9.
6
Endoscopic appearance of the GI lesions associated with Sweet's syndrome.
Gastrointest Endosc. 2000 Aug;52(2):287-9. doi: 10.1067/mge.2000.105978.
7
Long-Term Imaging Evolution and Clinical Prognosis Among Patients With Acute Penetrating Aortic Ulcers: A Retrospective Observational Study.
J Am Heart Assoc. 2020 Sep 15;9(18):e014505. doi: 10.1161/JAHA.119.014505. Epub 2020 Sep 6.
8
Endoscopic findings of gastrointestinal involvement in Chinese patients with Behcet's disease.
World J Gastroenterol. 2014 Dec 7;20(45):17171-8. doi: 10.3748/wjg.v20.i45.17171.
9
10
Penile ulcers complicating systemic AL amyloidosis: a case report.
Amyloid. 2016 Sep;23(3):203-204. doi: 10.1080/13506129.2016.1183477. Epub 2016 May 17.
引用本文的文献
1
Predictive value of gastrointestinal symptoms and patient risk factors for NSAID-associated gastrointestinal ulcers defined by endoscopy? Insights from a pooled analysis of two naproxen clinical trials.
PLoS One. 2023 Apr 13;18(4):e0284358. doi: 10.1371/journal.pone.0284358. eCollection 2023.
2
Assessing the Need for Proton Pump Inhibitors for Patients Using Long-Term Nonsteroidal Anti-inflammatory Drugs without a History of Ulcers.
Can J Hosp Pharm. 2020 May-Jun;73(3):216-217. Epub 2020 Jun 1.
3
Toward More GI-Friendly Anti-Inflammatory Medications.
Curr Treat Options Gastroenterol. 2015 Dec;13(4):377-85. doi: 10.1007/s11938-015-0064-9.
4
Comparative Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: A Network Meta-analysis.
Medicine (Baltimore). 2015 Jul;94(27):e974. doi: 10.1097/MD.0000000000000974.
5
Dosage effects of histamine-2 receptor antagonist on the primary prophylaxis of non-steroidal anti-inflammatory drug (NSAID)-associated peptic ulcers: a retrospective cohort study.
Drug Saf. 2014 Sep;37(9):711-21. doi: 10.1007/s40264-014-0209-0.
6
Endoscopic ulcers as a surrogate marker of NSAID-induced mucosal damage.
Arthritis Res Ther. 2013;15 Suppl 3(Suppl 3):S4. doi: 10.1186/ar4176. Epub 2013 Jul 24.
7
Fixed-dose ibuprofen/famotidine: a review of its use to reduce the risk of gastric and duodenal ulcers in patients requiring NSAID therapy.
Clin Drug Investig. 2013 Sep;33(9):689-97. doi: 10.1007/s40261-013-0113-x.
8
Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.
J Gastroenterol. 2014 May;49(5):814-24. doi: 10.1007/s00535-013-0839-5. Epub 2013 Jun 12.
9
Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.
World J Gastroenterol. 2013 Mar 28;19(12):1861-76. doi: 10.3748/wjg.v19.i12.1861.
10
Rofecoxib and clinically significant upper and lower gastrointestinal events revisited based on documents from recent litigation.
Am J Med Sci. 2011 Nov;342(5):356-64. doi: 10.1097/MAJ.0b013e3182113658.
本文引用的文献
1
Evidence for endoscopic ulcers as meaningful surrogate endpoint for clinically significant upper gastrointestinal harm.
Clin Gastroenterol Hepatol. 2009 Nov;7(11):1156-63. doi: 10.1016/j.cgh.2009.03.032. Epub 2009 Apr 9.
2
ACP Journal Club. What does it take to put an ugly fact through the heart of a beautiful hypothesis?
Ann Intern Med. 2009 Mar 17;150(6):JC3-2, JC3-3. doi: 10.7326/0003-4819-150-6-200903170-02002.
3
NSAIDs, risks, and gastroprotective strategies: current status and future.
Gastroenterology. 2008 Apr;134(4):1240-6. doi: 10.1053/j.gastro.2008.02.007.
4
Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications.
BMC Med. 2006 Sep 20;4:22. doi: 10.1186/1741-7015-4-22.
5
Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Am J Med. 2005 Nov;118(11):1271-8. doi: 10.1016/j.amjmed.2005.04.031.
6
Endoscopic ulcers with low-dose aspirin and reality testing.
Gastroenterology. 2005 Mar;128(3):807; author reply 807--8. doi: 10.1053/j.gastro.2005.01.022.
7
Surrogate endpoints and FDA's accelerated approval process.
Health Aff (Millwood). 2005 Jan-Feb;24(1):67-78. doi: 10.1377/hlthaff.24.1.67.
8
Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: results of a randomized double-blind trial.
Gastroenterology. 2004 Oct;127(4):1038-43. doi: 10.1053/j.gastro.2004.07.010.
9
Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis.
N Engl J Med. 2002 Dec 26;347(26):2104-10. doi: 10.1056/NEJMoa021907.
10
Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users.
Helicobacter. 2002 Feb;7(1):1-8. doi: 10.1046/j.1523-5378.2002.00048.x.
Zotero 插件